123.11 +0.30 (0.25%)
After hours: 4:26PM EDT
|Bid||122.69 x 800|
|Ask||122.72 x 800|
|Day's Range||122.58 - 123.83|
|52 Week Range||96.99 - 134.55|
|Beta (3Y Monthly)||1.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 26, 2019|
|Forward Dividend & Yield||0.96 (0.77%)|
|1y Target Est||135.19|
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a large-cap worth US$25b, comes to mind for investors seeking a strong and...
Zimmer Biomet Holdings Inc NYSE:ZBHView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ZBH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZBH. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.14 billion over the last one-month into ETFs that hold ZBH are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. ZBH credit default swap spreads are near the lowest level of the last one year and indicate improvement in the market's perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
NEW YORK , June 27, 2019 /PRNewswire/ -- Array BioPharma Inc. (ARRY) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ARRY to ...
WARSAW, Ind., June 19, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Daniel P. Florin will be retiring as Executive Vice President and Chief Financial Officer of the Company, effective July 1, 2019. Suketu (Suky) Upadhyay has been appointed to succeed Mr. Florin. To ensure a smooth and successful transition, and to assist in executing several ongoing cross-functional financial and operational initiatives, Mr. Florin will continue with the Company in an advisory capacity for a period following the succession.
WARSAW, Ind. , June 17, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter sales and earnings conference call will be broadcast over the Internet on ...
WARSAW, Ind. , June 11, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the ...
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of March 31. In this […]
NEW YORK, June 06, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Zimmer Biomet Holdings, Inc. (NYSE: ZBH)..
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of Zimmer Biomet Holdings, Inc. resulting from allegations that management may have issued materially misleading business information to the investing public.
SAN DIEGO, June 03, 2019 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: ZBH shares. Investors who purchased shares of.
PHILADELPHIA, PA / ACCESSWIRE / May 31, 2019 / Kaskela Law LLC has commenced an investigation of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH) on behalf ...
First quarter corporate report cards generally have been good, with 75% or so of S&P; 500 companies beating earnings estimates, observes John Buckingham, value investing expert and editor of The Prudent Speculator.
The Fed made a material reversal at year-end and lower interest rates have fueled gains for both stocks and bonds. Unprecedented technological innovation is driving impressive productivity gains which has helped to keep inflation in check. Where socialism grows so does inflation and stagnation.
On a per-share basis, the Warsaw, Indiana-based company said it had net income of $1.20. Earnings, adjusted for one-time gains and costs, came to $1.87 per share. The results surpassed Wall Street expectations. ...